• PNB Housing to price $450m IPO at the top

    PNB Housing Finance is set to price its Rp30bn ($450m) IPO in India at the top of the expected range after investors piled into the trade, allowing it to wrap up with books 30x covered.

    • 11:45 AM
  • PNB Housing, Varun IPOs get star treatment

    Investors have greeted India’s latest IPOs with open arms, as PNB Housing Finance and Varun Beverages seek to raise Rp41.1bn ($616.9m) this week.

    • 27 Oct 2016
  • Busy week for investors with four HK IPOs in limelight

    Chinese fashion house JNBY sealed a HK$800.0m ($103.1m) IPO this week after pricing off the bottom of guidance, according to a source close to the deal.

    • 27 Oct 2016
  • HK IPO round-up: FIT Hon Teng, Kanghua, Dazhong

    Guangdong Kanghua Healthcare Co has gone live with its Hong Kong IPO and begun taking orders for a HK$1.2bn ($154.7m) listing.

    • 26 Oct 2016
  • Varun Beverages pops open $167m India IPO

    India’s Varun Beverages opened books to its Rp11.1bn ($166.6m) IPO on Wednesday, with anchor investors taking up their full allocation at the top of the price range.

    • 26 Oct 2016
  • MTR’s debut green bond thrives on strong EU demand

    Hong Kong rail operator MTR Corp sold its debut green bond on Monday, attracting orders worth $1.4bn. The deal saw strong support from European accounts in particular, thanks to the rarity and quality of the credit.

    • 25 Oct 2016
  • Lippo builds first 10 year with strong demand

    Indonesian property developer Lippo Karawaci excited investors on Monday with its roll out of a longer tenor, high yield bond.

    • 25 Oct 2016
  • Korea's Hotel Lotte to revive IPO plans

    South Korea's Hotel Lotte Co is planning to return to equity capital markets in the near future with another IPO attempt, chairman Shin Dong-bin said in a press briefing on Tuesday.

    • 25 Oct 2016
  • PNB Housing, Varun see huge take up for IPOs

    PNB Housing Finance has launched its Rp30bn ($449m) IPO, India’s second largest this year, to an enthusiastic response from anchor investors as the country's FIG names continue to draw interest.

    • 25 Oct 2016
  • Lippo to push back maturity profile with new bond

    Indonesian property developer Lippo Karawaci is continuing its efforts to push out its debt maturity profile with a new 10 non call five bond.

    • 24 Oct 2016
  • Hong Kong’s MTR on track for green debut

    Hong Kong underground rail operator MTR Corp is selling a 10 year green bond and is set to become only the second green debt issuer from the city.

    • 24 Oct 2016
  • Kaboom! CR Pharma listing fetches $1.8bn

    China Resources Pharmaceutical Group priced its Hong Kong IPO near the middle of expectations on Friday morning, raising HK$14bn ($1.8bn) after investors stormed into the trade.

    • 21 Oct 2016
  • ICBC NY drops 10yr on pricing expectations mismatch

    Industrial and Commercial Bank of China’s New York branch was forced to scrap a 10 year portion of a dual tranche bond on Monday because of a disagreement with investors over what it should pay. But all was not lost, as the issuer decided to make the most of the demand for the shorter tenor, taking home $1bn in the end, writes Addison Gong.

    • 20 Oct 2016
  • Asia trio reel in crowds with $1bn-plus IPOs

    China Resources Pharmaceutical Group, Samsung BioLogics and ZTO Express all have investors clamouring to join their IPOs, as they look to raise a combined $5.2bn.

    • 20 Oct 2016
  • CR Pharma narrows range on HK$15bn IPO

    China Resources Pharmaceutical Group has tightened the price range on its IPO, putting it on track to raise up to HK$14.8bn ($1.9bn), according to a banker on the deal.

    • 20 Oct 2016
  • Varun, PNB Housing eye $617m from IPOs

    PNB Housing Finance and Varun Beverages are launching their IPOs in India next week to raise a combined Rp41.1bn ($616.9m).

    • 19 Oct 2016
  • Investors after strong dose of CR Pharma IPO

    China Resources Pharmaceutical Group is proving a hit with global investors, as its HK$15.7bn ($2.0bn) Hong Kong IPO is heavily oversubscribed, according to a banker at one of the leads.

    • 18 Oct 2016
  • ICBC NY scraps 10 year tranche on pricing mismatch

    Industrial and Commercial Bank of China’s New York branch decided to scrap a 10 year portion of a dual-trancher on Monday, as mismatch on pricing led to investors shunning the tenor in favour of a five year.

    • 18 Oct 2016
  • Cheung Kong Property builds plan for new bond

    Hong Kong's Cheung Kong Property Holdings is looking to take advantage of a recent rating upgrade to ready a bond offering.

    • 17 Oct 2016
  • BDO Unibank, ICBC NY lead the charge in FIG issuance

    BDO Unibank in the Philippines and Industrial and Commercial Bank of China New York branch made their respective returns to the dollar bond market on Monday.

    • 17 Oct 2016
  • Kexim, Mexim seize the day with well received bonds

    Export-Import Bank of Korea (Kexim) executed yet another blockbuster $2.5bn trade on Thursday just a few months after printing a deal of the same size. Korea's first four-tranche trade drew a strong response from the market, allowing the policy bank to price inside its existing curve.

    • 14 Oct 2016
  • Retail lenders get just 1/3 of Tencent $3.5bn Supercell loan

    A $3.5bn dual-tranche borrowing to back Tencent Holdings' acquisition of a stake in mobile gaming company Supercell, has been allocated. Three Chinese mandated lead arrangers and bookrunners held on to 60% of the loan at the end of general syndication.

    • 14 Oct 2016
  • Show of strength for CR Pharma as $2bn IPO launches

    China Resources Pharmaceutical Group’s HK$15.7bn ($2.0bn) Hong Kong IPO got off to a flying start this week, with books covered and support from high profile cornerstone investors giving it momentum.

    • 13 Oct 2016
  • Asian borrowers storm debt market

    A diverse group of issuers forged ahead with their respective fundraisings on Thursday, seeking everything from dollars to Singapore dollars and green debt.

    • 13 Oct 2016
  • Updated: CR Pharma $2bn IPO nets big name cornerstones

    China Resources Pharmaceutical Group has lined up eight cornerstone investors for its HK$15.6bn ($2.0bn) Hong Kong IPO, with the group agreeing to buy $916m worth of shares.

    • 12 Oct 2016
  • CR Pharma sets price range for $2bn HK IPO

    China Resources Pharmaceutical Group will raise as much as HK$15.6bn ($2.0bn) via a Hong Kong IPO after firming up the price range.

    • 11 Oct 2016
  • ECM giants lose ground as Asia opens up, Emea block market changes

    With one quarter left of 2016 to go and global issuance 22% down, the equity capital markets bookrunner race is going into its final straight. Familiar faces are leading the pack, but incumbents in general are having a tough year.

    • 10 Oct 2016
  • Aoyuan Property builds up steam on positive outlook

    China Aoyuan Property has mandated banks to organise fixed income investor meetings to update the market on recent news about its credit.

    • 06 Oct 2016
  • BAML loses head of southeast Asia ECM, equity-linked

    Bank of America Merrill Lynch’s head of southeast Asia equity capital markets has left the firm, amid a wider reshuffle of its Asian investment banking business that resulted in a number of departures.

    • 04 Oct 2016

All International Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 24 Oct 2016
1 JPMorgan 317,793.98 1355 8.72%
2 Citi 301,114.13 1092 8.26%
3 Barclays 259,580.63 846 7.12%
4 Bank of America Merrill Lynch 258,842.43 934 7.10%
5 HSBC 224,273.23 905 6.15%

Bookrunners of All Syndicated Loans EMEA

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 25 Oct 2016
1 JPMorgan 32,854.00 58 6.73%
2 BNP Paribas 31,678.29 142 6.49%
3 UniCredit 31,604.22 138 6.47%
4 HSBC 25,798.87 114 5.29%
5 ING 21,769.65 121 4.46%

Bookrunners of all EMEA ECM Issuance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 25 Oct 2016
1 JPMorgan 14,633.71 80 10.23%
2 Goldman Sachs 11,731.14 63 8.20%
3 Morgan Stanley 9,435.23 48 6.60%
4 Bank of America Merrill Lynch 9,229.95 42 6.45%
5 UBS 8,781.68 42 6.14%